A Case Study By Device Access UK Ltd

Device Access supported NxThera a novel Minneapolis based company in growing their urology business through the NHS. Their initial goal was to find UK NHS Centres interested in a clinical study to show that the new treatment for prostate could be utilised in the NHS. Device Access worked collaboratively with the NIHR, NICE and NHS England to support the introduction and growth of the technology into the NHS. This resulted in a positive NICE evaluation and subsequent acquisition of the business by Boston Scientific UK. Device Access helped demonstrate the affordability of the technology though NICE and helped identify centres of excellence and NHS Centres that would benefit most from the new key hole treatment.